1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.           Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics

4.1       Middle East & Africa Vaccine Adjuvants Market – Key Market Dynamics

4.2       Market Drivers

4.2.1         Rising Number of Infectious Disease Outbreaks and Pandemic

4.2.2         Approvals of Veterinary Vaccine Adjuvants

4.3       Market Restraints

4.3.1         Product Recalls and Adverse Effects

4.4       Market Opportunities

4.4.1         Advancements in Biotechnology and Immunology

4.5       Future Trends

4.5.1         Technological Advancements

4.6       Impact of Drivers and Restraints:

5.           Vaccine Adjuvants Market –Middle East & Africa Market Analysis

5.1       Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

5.2       Middle East & Africa Vaccine Adjuvants Market Forecast and Analysis

6.           Middle East & Africa Vaccine Adjuvants Market Analysis –by Adjuvant Class

6.1       Overview

6.2       Mineral Salt Adjuvant

6.2.1         Overview

6.2.2         Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.3       Emulsion Adjuvant

6.3.1         Overview

6.3.2         Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.4       Liposome Adjuvant

6.4.1         Overview

6.4.2         Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

6.5       Others

6.5.1         Overview

6.5.2         Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.           Middle East & Africa Vaccine Adjuvants Market Analysis – by Type

7.1       Human Vaccine Adjuvant

7.1.1         Overview

7.1.2         Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

7.2       Veterinary Vaccine Adjuvant

7.2.1         Overview

7.2.2         Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.           Middle East & Africa Vaccine Adjuvants Market –Country Analysis

8.1       Middle East & Africa

8.1.1         Middle East & Africa: Vaccine Adjuvants Market – Revenue and Forecast Analysis – by Country

8.1.1.1            Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.1           Overview

8.1.1.1.2           Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.1.3           Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.1.4           Saudi Arabia: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.2            South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.1           Overview

8.1.1.2.2           South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.2.3           South Africa: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.2.4           South Africa: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.3            United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.1           Overview

8.1.1.3.2           United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.3.3           United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.3.4           United Arab Emirates: Vaccine Adjuvants Market Breakdown, by Type

8.1.1.4            Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.1           Overview

8.1.1.4.2           Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

8.1.1.4.3           Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Adjuvant Class

8.1.1.4.4           Rest of Middle East and Africa Vaccine Adjuvants Market Breakdown, by Type

9.           Industry Landscape

9.1       Overview

9.2       Growth Strategies in the Global Vaccine Adjuvants Market

9.3       Organic Developments

9.3.1         Overview

9.4       Inorganic Developments

9.4.1         Overview

10.        Company Profiles

10.1     GSK Plc

10.1.1       Key Facts

10.1.2       Business Description

10.1.3       Products and Services

10.1.4       Financial Overview

10.1.5       SWOT Analysis

10.1.6       Key Developments

10.2     CSL Ltd

10.2.1       Key Facts

10.2.2       Business Description

10.2.3       Products and Services

10.2.4       Financial Overview

10.2.5       SWOT Analysis

10.2.6       Key Developments

10.3     Croda International Plc

10.3.1       Key Facts

10.3.2       Business Description

10.3.3       Products and Services

10.3.4       Financial Overview

10.3.5       SWOT Analysis

10.3.6       Key Developments

10.4     Novavax Inc

10.4.1       Key Facts

10.4.2       Business Description

10.4.3       Products and Services

10.4.4       Financial Overview

10.4.5       SWOT Analysis

10.4.6       Key Developments

10.5     Phibro Animal Health Corp

10.5.1       Key Facts

10.5.2       Business Description

10.5.3       Products and Services

10.5.4       Financial Overview

10.5.5       SWOT Analysis

10.5.6       Key Developments

11.        Appendix

11.1     About The Insight Partners

List of Tables

Table 1.             Middle East & Africa Vaccine Adjuvants Market Segmentation

Table 2.             Middle East & Africa Vaccine Adjuvants Market Revenue and Forecasts To 2030 (US$ Million)

Table 3.             Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 4.             Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 5.             South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 6.             South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 7.             United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 8.             United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 9.             Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Adjuvant Class

Table 10.          Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million) – by Type

Table 11.          Organic Developments Done by Companies

Table 12.          Inorganic Developments Done by Companies

List of Figures

Figure 1.           Middle East & Africa Vaccine Adjuvants Market Segmentation, by Country

Figure 2.           Impact Analysis of Drivers and Restraints

Figure 3.           Middle East & Africa Vaccine Adjuvants Market Revenue (US$ Million), 2022–2030

Figure 4.           Middle East & Africa Vaccine Adjuvants Market Share (%) – by Adjuvant Class (2022 and 2030)

Figure 5.           Mineral Salt Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 6.           Emulsion Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7.           Liposome Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8.           Others: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9.           Middle East & Africa Vaccine Adjuvants Market Share (%) – by Type (2022 and 2030)

Figure 10.        Human Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 11.        Veterinary Vaccine Adjuvant: Middle East & Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Middle East and Africa Vaccine Adjuvants Market by Key Countries – Revenue 2022 (US$ Million)

Figure 13.        Middle East and Africa Vaccine Adjuvants Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 14.        Saudi Arabia: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 15.        South Africa: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 16.        United Arab Emirates: Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 17.        Rest of Middle East and Africa Vaccine Adjuvants Market – Revenue and Forecast to 2030(US$ Million)

Figure 18.        Growth Strategies in the Vaccine Adjuvants Market